Investor Relations

2017 Press Releases

Receive E-mail AlertsE-mail Alerts
RSS RSS Feeds
Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
11/13/17Vanda Pharmaceuticals Announces Participation at November 2017 Investor ConferencesPrinter Friendly Version
11/10/17Vanda Receives Negative Opinion for Marketing Authorization from the European Medicines Agency on Fanaptum™ for the Treatment of SchizophreniaPrinter Friendly Version
11/07/17Vanda Pharmaceuticals Reports Third Quarter 2017 Financial ResultsPrinter Friendly Version
10/24/17Vanda Pharmaceuticals to Announce Third Quarter 2017 Financial Results on November 7, 2017Printer Friendly Version
10/10/17Vanda Pharmaceuticals Announces Participation at the Oppenheimer Specialty Pharma Summit ConferencePrinter Friendly Version
10/02/17Vanda to Present Tradipitant Phase II Atopic Dermatitis Data at World Congress of ItchPrinter Friendly Version
09/29/17Vanda to Present Scientific Posters at World Sleep 2017Printer Friendly Version
09/13/17Vanda's Tradipitant Improves Itch and Disease Severity in Patients with Atopic DermatitisPrinter Friendly Version
09/11/17Vanda Pharmaceuticals Announces Participation at September 2017 Investor ConferencesPrinter Friendly Version
09/06/17Vanda Pharmaceuticals Announces Participation at the Citi 12th Annual Biotech ConferencePrinter Friendly Version
08/02/17Vanda Pharmaceuticals Reports Second Quarter 2017 Financial ResultsPrinter Friendly Version
07/21/17Vanda Receives Negative Opinion for Marketing Authorization from the European Medicines Agency on Fanaptum™ for the Treatment of SchizophreniaPrinter Friendly Version
07/17/17Vanda Pharmaceuticals to Announce Second Quarter 2017 Financial Results on August 2, 2017Printer Friendly Version
06/05/17Vanda Pharmaceuticals Announces Participation at June 2017 Investor ConferencesPrinter Friendly Version
05/02/17Vanda Pharmaceuticals Reports First Quarter 2017 Financial ResultsPrinter Friendly Version
05/01/17Vanda Pharmaceuticals to Present at the Deutsche Bank 42nd Annual Health Care ConferencePrinter Friendly Version
04/13/17Vanda Pharmaceuticals to Announce First Quarter 2017 Financial Results on May 2, 2017Printer Friendly Version
03/29/17Vanda and UCSF Announce License Agreement for CFTR Activators and InhibitorsPrinter Friendly Version
03/06/17Vanda Pharmaceuticals Announces Participation at March 2017 Investor ConferencesPrinter Friendly Version
02/15/17Vanda Pharmaceuticals Reports Fourth Quarter 2016 and Full Year 2016 Financial ResultsPrinter Friendly Version
01/19/17Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2016 Financial Results on February 15, 2017Printer Friendly Version
01/09/17Vanda Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2016 Revenue Results and 2017 Financial GuidancePrinter Friendly Version
  
Home | About Vanda | Product Pipeline| Partnering | Investor Relations | News | Careers | Contact Us
Copyright © 2005-2017 Vanda Pharmaceuticals | Terms & Conditions | Privacy Policy